Request Trial
patenting214054975
science photo / Shutterstock.com
4 November 2014BiotechFranz-Josef Zimmer and Markus Grammel

Patenting Parthenotes

Against the backdrop of an increasingly unfavourable European legal landscape for human stem cell patents (see LSIPR 2014, 1.3), in his recent opinion in case C-364/13 the Advocate General (AG) Pedro Cruz Villalón of the Court of Justice of the European Union (CJEU) gives reason to believe that there is some light on the horizon for applicants seeking patent protection for stem cell-related inventions.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotech
Illumina ordered to recall products after German patent ruling
16 July 2026   A Munich court ruled that Illumina infringed a rival’s DNA sequencing patents, handing the challenger an early victory in a dispute that is playing out across Europe and the US.
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026   French drugmaker's Translate Bio unit accuses COVID rivals of infringing core lipid nanoparticle and mRNA purification patents, seeking damages from vaccines worth billions.
Biotech
Explaining genetically engineered rodents to a jury—and ultimately beating Amgen
10 July 2026   Harbour’s trial counsel shares the strategy behind the company’s $20m win, revealing how a highly technical patent dispute became a case about credibility as much as science.


Editor's picks

Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026

Editor's picks

Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026
Regulation & Industry
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026
Regulation & Industry
Insilico lands potential $2.5bn AI biotech partnership
22 June 2026
Regulation & Industry
US life sciences damages averaged $33.5m between 2019-2025
18 June 2026
Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026

More features

Why is 2026 already a record year for M&A activity?
Illumina ordered to recall products after German patent ruling
Goodwin launches San Diego office with senior life sciences hire
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
UK-Switzerland strike trade deal with first-of-its-kind pharma rules
Interview: How BlueRock Therapeutics is layering IP in stem cell therapies
Explaining genetically engineered rodents to a jury—and ultimately beating Amgen
UPC upholds injunction in Invisalign maker’s software dispute with rival